In this webinar, you will…

  • Learn the details of LC-MS based antibody characterization in early discovery and production pipelines
  • Explore in-depth the analytical methodologies and strategies essential for comprehensive antibody characterization, covering post-translational modifications, glycan profiles, peptide mapping, and disulfide linkages
  • Ask your burning questions and get expert guidance on navigating antibody characterization

Abstract

Antibody characterization using liquid chromatography-mass spectrometry (LC-MS) provides critical insights in the later stages of discovery and early stages of preclinical production. Moreover, it plays a crucial role in informing antibody optimization, formulation development, and ensuring regulatory compliance for antibody-based therapeutics.

Join our experts – Dr. Jinrui Gan and Anthony Stajduhar – as they guide you through the significance of LC-MS in antibody characterization and delve into the intricacies of analytical methods essential for analyzing post-translational modifications, glycan profiles, peptide mapping, and disulfide linkages.

Seize this opportunity to engage with experts and ask your questions about antibody characterization.

Speaker Bios

Webinar

Integrating AI and HDX-MS for Antibody Epitope Mapping

July 11 2024, 10:00AM EST | 16:00 CET

Talk to Our Scientists.

We Have Sequenced 9000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.

Talk to Our Scientists.

We Have Sequenced 9000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics

Talk to our scientists. We have sequenced over 9000+ antibodies and we are eager to help you.